Navigation Links
Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
Date:2/23/2009

nal human clinical trials with our product candidates, that our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future preclinical and clinical development may not have positive results, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates, that our projected burn rate may not be consistent with our expectations, that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (filed November 28, 2008), Quarterly Reports on Form 10-Q, current reports on Form 8-K which identify important factors that could cause the actual results to differ materially from those contained in the projections or forward-looking statements.

BCRXW


'/>"/>
SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
2. Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
3. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
4. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
5. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
6. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
7. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
8. Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results
9. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
10. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
11. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... September 2, 2015 According to ... Product (Digital & Computed Radiography, Ultrasound, Computed & Optical ... by Application (Oncology, Cardiology, Neurology) - Global Forecast to ... reach USD 2.8 Billion by 2020 growing at a ... Br owse 240 Tables and 44 F ...
(Date:9/2/2015)... and TORONTO ... Corporation ( www.generex.com ) (OTCQB: GNBT) today ... implement a buccal cannabis co-development arrangement with ... been formalized. Generex and CannScience ... Technology Licensing Agreement.  Pursuant to the Agreement, ...
(Date:9/2/2015)... ROCKVILLE, Md. , Sept. 2, 2015 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... J.J. Finkelstein , President and Chief Executive ... Rodman & Renshaw Global Investment Conference, sponsored by ... will be held September 8-10, 2015 at the ...
Breaking Medicine Technology:Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3
... Tissue Oncology, Society held in Seattle, Washington demonstrates clinical ... single agent in patients with ... chemo-insensitive sarcomas, NEW YORK, Nov. ... preliminary data demonstrating the,tolerability and clinical activity of KRX-0401 (perifosine) in ...
... (ASX: PGL; Nasdaq: PGLA) today announced additional,data from the ... this,year. This data was presented at the 58th Annual ... Diseases in Boston, USA(1). As the Phase 2 ... data analysis described in this presentation was performed to,evaluate ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3
(Date:9/2/2015)... ... ... Every year at this time, students prepare to go back to school. ... the academic workload confronting them. They just don’t have the skills needed to do ... students how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job of ...
(Date:9/2/2015)... ... September 02, 2015 , ... Amada Senior Care, premier provider ... Kansas – its Johnson County location. Amada franchise partners Mike and Mell ... registered nurse background and spent over 20 years in medical device sales while Mell ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Fort Lauderdale, CENTURION SERVICE GROUP is internationally known as an industry leader specializing ... house in the world, selling more than 100,000 pieces of medical equipment every ...
(Date:9/2/2015)... Utah (PRWEB) , ... September 02, 2015 , ... On ... Utah to attend doTERRA’s annual convention, the largest single-company convention to date for the ... Advocates and look forward to a tremendous event,” states David Stirling, doTERRA CEO. “One ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream , ... combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for intense nourishing ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4
... venom of the brown recluse spider, researchers at the University ... to open// molecular pores, called ion channels, in the membrane ... Lu, MD, PhD; Yajamana Ramu, PhD; and Yanping Xu, MD, ... venoms from over 100 poisonous invertebrate species to make this ...
... today launched a new vision correction technology, Zyoptix Aspheric, ... ,"There are 60 clinics all across India which use ... be upgraded to Zyoptix Aspherix which further reduces post ... and Lomb India Director-Surgical business Rajat Goel told reporters ...
... like corks to block oxygen flow to tumors, or to ... to a tumor is called embolization, and using gas bubbles ... promising is that the technique allows doctors to control exactly ... to surrounding tissue is minimal, said Joseph Bull, assistant professor ...
... by Dr. Adam Godzik at the Burnham Institute for ... understanding of information gathered// from the human genome project. ... a three year period, this consortium, under the name ... adequate support to scientists from Burnham and UCSD's Computer ...
... labs of Yale Goldman, MD, PhD, Director of the ... of Medicine,// and Erika Holzbaur, PhD, Professor of Physiology, ... show proteins that function as molecular motors are surprisingly ... cell. These observations could lead to better ways to ...
... Once a month osteoporisis drug and extra telephone support from ... among women for their drug treatment// than those who took ... issue of IJCP, the International Journal of Clinical Practice. ... part in the PERSIST study between January 2005 and January ...
Cached Medicine News:Health News:New Way to Open Cellular Ion Channels, Implications for Drug Design 2Health News:Researchers Use Bubbles in Cancer Treatment and Drug Delivery 2Health News:Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego 2Health News:Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases 2Health News:Women More Persistent with Monthly Osteoporosis Treatment 2
... The Stryker Cross-Screw System ... and secure method for ACL ... The Stryker Cross-Screw System provides ... fixation. The implant comes in ...
... Universal Wedge Screw is a ... cruciate reconstruction and is indicated ... grafts. The Universal Wedge Screw ... has blunt threads which protect ...
... The Stryker Threaded ... surgeon yet another choice ... tunnel. Dilators provide compaction ... The compaction of bone ...
... The Stryker Conquest Suture ... instruments that pierce through ... suture through the tissue ... The Conquest Retrievers are ...
Medicine Products: